CoChat
Sign Up
Cited by 174Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesCytokine Signaling Pathways and Interactions

The DOI matches its Crossref record; 62 of the 67 references it cites were found in a registry or an index, and 5 are not checked yet.

Leptin signaling

Open access
Park, Hyeong-Kyu, Ahima, Rexford S.·2014·F1000Prime Reports
DOI 10.12703/p6-73PMC PMC4166933
Open this paper in CoChat — free accountOpen PDF

Abstract

Leptin is secreted by adipose tissue and regulates energy homeostasis, glucose and lipid metabolism, immune function, and other systems. The binding of leptin to its specific receptor activates various intracellular signaling pathways, including Janus kinase 2 (JAK2)/ signal transducer and activator of transcription 3 (STAT3), insulin receptor substrate (IRS)/phosphatidylinositol 3 kinase (PI3K), SH2-containing protein tyrosine phosphatase 2 (SHP2)/mitogen-activated protein kinase (MAPK), and 5' adenosine monophosphate-activated protein kinase (AMPK)/ acetyl-CoA carboxylase (ACC), in the central nervous system and peripheral tissues. Understanding of leptin signaling provides insights into its roles in health and disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12703/p6-73

Cites

62 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Multiple leptin signaling pathways The binding of leptin to the long isoform of leptin receptor (LepRb) results in its dimerization, leading to the formation of the LepRb/Janus kinase 2 (JAK2) complex. The activated JAK2 phosphorylates itself and also Tyr985, Tyr1077, and Tyr1138 in LepRb. Signal transducer and activator of transcription (STAT) 3 and STAT5 bind to phospho-Tyr1138 and phospho-Tyr1077 in LepRb and are subsequently phosphorylated. Active STAT3 and STAT5 dimers then translocate to the nucleus and activate the transcription of their target genes, which mediate leptin's anorexigenic effect. Suppressor of cytokine signaling 3 (SOCS3), a target gene of STAT3, inhibits the JAK2/STAT3 pathway by interacting with phospho-Tyr985 or JAK2 and acting as a feedback inhibitor of leptin signaling. Protein tyrosine phosphatase 1B (PTP1B) also inhibits leptin signaling through dephosphorylation of JAK2. After JAK2 activation, SH2-containing protein tyrosine phosphatase 2 (SHP2) binds to phospho-Tyr985 in the LepRb and recruits the adaptor protein growth factor receptor-bound protein 2 (Grb2), leading to activation of the mitogen-activated protein kinase (MAPK) signaling cascade. Leptin activates MAPK independent of SHP2 and also regulates phosphatidylinositol 3 kinase (PI3K) signaling through insulin receptor substrate (IRS) phosphorylation. Forkhead box O1 (FoxO1), mammalian target of rapamycin (mTOR), and phosphodiesterase 3B (PDE3B) are important downstream targets of PI3K in the leptin signaling pathway. Leptin regulates feeding and metabolism through 5' adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) in the brain and peripheral organs.
Figure 1. Multiple leptin signaling pathways The binding of leptin to the long isoform of leptin receptor (LepRb) results in its dimerization, leading to the formation of the LepRb/Janus kinase 2 (JAK2) complex. The activated JAK2 phosphorylates itself and also Tyr985, Tyr1077, and Tyr1138 in LepRb. Signal transducer and activator of transcription (STAT) 3 and STAT5 bind to phospho-Tyr1138 and phospho-Tyr1077 in LepRb and are subsequently phosphorylated. Active STAT3 and STAT5 dimers then translocate to the nucleus and activate the transcription of their target genes, which mediate leptin's anorexigenic effect. Suppressor of cytokine signaling 3 (SOCS3), a target gene of STAT3, inhibits the JAK2/STAT3 pathway by interacting with phospho-Tyr985 or JAK2 and acting as a feedback inhibitor of leptin signaling. Protein tyrosine phosphatase 1B (PTP1B) also inhibits leptin signaling through dephosphorylation of JAK2. After JAK2 activation, SH2-containing protein tyrosine phosphatase 2 (SHP2) binds to phospho-Tyr985 in the LepRb and recruits the adaptor protein growth factor receptor-bound protein 2 (Grb2), leading to activation of the mitogen-activated protein kinase (MAPK) signaling cascade. Leptin activates MAPK independent of SHP2 and also regulates phosphatidylinositol 3 kinase (PI3K) signaling through insulin receptor substrate (IRS) phosphorylation. Forkhead box O1 (FoxO1), mammalian target of rapamycin (mTOR), and phosphodiesterase 3B (PDE3B) are important downstream targets of PI3K in the leptin signaling pathway. Leptin regulates feeding and metabolism through 5' adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) in the brain and peripheral organs.CC BY-NC · PubMed Central
Figure 2. Interactions of leptin and insulin signaling in hypothalamus Leptin activates signal transducer and activator of transcription (STAT) 3 when it binds to the long isoform of leptin receptor (LepRb) in the arcuate nucleus, ventromedial hypothalamus, and other hypothalamic neurons. Activated STAT3 stimulates pomc expression and inhibits agrp expression in the hypothalamus. Leptin and insulin signaling pathways converge on phosphatidylinositol 3 kinase (PI3K). Activation of PI3K by either leptin or insulin leads to phosphorylation of Forkhead box O1 (FoxO1) through Akt, which can also activate the mammalian target of rapamycin (mTOR). Inactivation of FoxO1 by phosphorylation results in its export from the nucleus and allows for the binding of STAT3 to pomc or agrp promoter. In addition, the leptin-mediated activation of PI3K recruits phosphodiesterase 3B (PDE3B), thereby reducing cAMP (cyclic adenosine monophosphate) levels. STAT3 increases the expression of suppressor of cytokine signaling 3 (SOCS3), which leads to feedback inhibition of leptin and insulin signaling. Abbreviation: JAK2, Janus kinase 2.
Figure 2. Interactions of leptin and insulin signaling in hypothalamus Leptin activates signal transducer and activator of transcription (STAT) 3 when it binds to the long isoform of leptin receptor (LepRb) in the arcuate nucleus, ventromedial hypothalamus, and other hypothalamic neurons. Activated STAT3 stimulates pomc expression and inhibits agrp expression in the hypothalamus. Leptin and insulin signaling pathways converge on phosphatidylinositol 3 kinase (PI3K). Activation of PI3K by either leptin or insulin leads to phosphorylation of Forkhead box O1 (FoxO1) through Akt, which can also activate the mammalian target of rapamycin (mTOR). Inactivation of FoxO1 by phosphorylation results in its export from the nucleus and allows for the binding of STAT3 to pomc or agrp promoter. In addition, the leptin-mediated activation of PI3K recruits phosphodiesterase 3B (PDE3B), thereby reducing cAMP (cyclic adenosine monophosphate) levels. STAT3 increases the expression of suppressor of cytokine signaling 3 (SOCS3), which leads to feedback inhibition of leptin and insulin signaling. Abbreviation: JAK2, Janus kinase 2.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

Sorted by citations

See all 174

Related

See all

Metadata

Authors
Park, H.-K., & Ahima, R. S.
Affiliations
  • Soonchunhyang University (KR)
  • University of Pennsylvania (US)
Corresponding author
Ahima, Rexford S.
ORCID
Ahima, Rexford S.
Venue
F1000Prime Reports
Publisher
H1 Connect
Published
2014-09-04
Volume
6
Pages
73-73
ISSN
2051-7599 (ISSN-L)
DOI
10.12703/p6-73
PMC
PMC4166933
OpenAlex
W4252710559
Cited by
171
References
62
Citations by year
2026: 6 · 2025: 18 · 2024: 18 · 2023: 15 · 2022: 20 · 2021: 16 · 2020: 23 · 2019: 13 · 2018: 5 · 2017: 7 · 2016: 14 · 2015: 15 · 2014: 1
FWCI
1.39
Type
journal article
Language
en
Open access
Locations
  • F1000Prime Reports (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (DK049210, DK 19525)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P01DK049210, P30DK019525)
  • National Institute of Neurological Disorders and Stroke (R01NS084965)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Keywords
leptin, leptin signaling, leptin receptor, energy homeostasis, glucose metabolism, lipid metabolism, immune function, JAK2/STAT3 signaling, adipose tissue, central nervous system

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review